Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Compugen Expands Clinical Collaboration Agreement with Bristol Myers Squibb with Phase 1b Combination Study of COM701 with Opdivo®
Tuesday, February 23, 2021Compugen Ltd a clinicalstage cancer immunotherapy company and a leader in predictive target discovery announced the expansion of its clinical collaboration agreement with Bristol Myers Squibb
SunRock Biopharma and GenScript ProBio to develop new monoclonal antibody program
Tuesday, February 23, 2021GenScript ProBio and SunRock Biopharma a company focused on developing cancertargeted antibody therapeutics announced a collaboration spanning preclinical discovery for largescale GMP manufacturing for SunRocks CCR therapeutic antibody candidates
NMPA Approves Toripalimab in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma after Failure of at Least Two Lines of Prior Systemic Therapy
Monday, February 22, 2021Junshi Biosciences a leading innovationdriven biopharmaceutical company dedicated to the discovery development and commercialization of novel therapies announced today that the National Medical Products Administration NMPA of China has granted a cond...
ForDoz Enters Contract Manufacturing Agreement for Oncology Liposomal Product with LipoMedix
Saturday, February 20, 2021ForDoz Pharma has entered into an agreement with LipoMedix for manufacturing its lead compound pegylated liposomal Promitil PLMLP for a Phase clinical studyPromitils unique liposomal formulation is designed for selective delivery of the therapeutic...
Lilly and Rigel Enter Strategic Collaboration to Develop RIPK1 Inhibitors for the Potential Treatment of Immunological and Neurodegenerative Diseases
Friday, February 19, 2021Eli Lilly and Company and Rigel Pharmaceuticals Inc announced a global exclusive license agreement and strategic collaboration to codevelop and commercialize Rigels R a receptorinteracting serinethreonineprotein kinase RIPK inhibitor
Boston Immune Technologies and Therapeutics and BeiGene Enter into an Exclusive Option and License Agreement to Develop Novel TNFR2 Antagonists
Friday, February 19, 2021Boston Immune Technologies and Therapeutics Inc BITT a privately held developer of novel antagonist antibodies for cancer and other diseases and BeiGene Ltd announced that they have entered into an option and license agreement aimed at developing and...
Provention Bio and Huadong Announce Strategic Collaboration to Develop and Commercialize PRV-3279 in Greater China
Thursday, February 18, 2021Provention Bio Inc a biopharmaceutical company dedicated to intercepting and preventing immunemediated diseases and Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd a whollyowned subsidiary of Huadong Medicine Co Ltd
GSK and Vir Biotechnology Expand Coronavirus Collaboration to Advance New Therapeutics for Influenza and Other Respiratory Viruses
Thursday, February 18, 2021GlaxoSmithKline plc and Vir Biotechnology Inc announced they have signed a binding agreement to expand their existing collaboration to include the research and development of new therapies for influenza and other respiratory viruses
AliveCor Announces Collaboration with AstraZeneca to Develop Non-Invasive Potassium Monitoring Solutions
Wednesday, February 17, 2021AliveCor the leader in AIbased personal ECG technology and provider of enterprise cardiology solutions announced a new collaboration with AstraZeneca a global scienceled biopharmaceutical company
Iterion Therapeutics Secures $17 Million to Advance Development of Tegavivint in Multiple Tumor Settings
Wednesday, February 17, 2021Iterion Therapeutics Inc Iterion a venturebacked clinical stage biotechnology company developing novel cancer therapeutics announced that it has raised million USD in a Series B financing led by Lumira Ventures
